Friedreich's Ataxia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia
Condition: Friedreich Ataxia Interventions: Drug: DT-216; Drug: DT-216 matching Placebo Sponsor: Design Therapeutics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2022 Category: Research Source Type: clinical trials
